Pluristem Therapeutics Inc (PSTI)

[Crustacener]

Very positive article:
https://www.painnewsnetwork.org/stories/2020/5/11/the-fdas-stem-cell-reformation-must-proceed-beyond-covid-19

The COVID-19 crisis has been a catalyst for new regulatory flexibility at the U.S. Food and Drug Administration. The FDA is pushing aggressively to develop new vaccines and treatments for coronavirus, including dozens of clinical trials of stem cell therapies on critically ill patients.

...A stem cell reformation of sorts is underway at the FDA due to the coronavirus pandemic.

...The FDA's current push for stem cell innovation must proceed beyond the therapeutic necessity of coronavirus.

GLTA